King Pharmaceuticals, Inc.
Records under this name other than patents King Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to King Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,747,019 | Low dose estrogen interrupted hormone replacement therapy Formerly held Term ended Term ended Mar 30, 2020 · From the USPTO record | Term ended | Term ended Mar 30, 2020 | From the USPTO record |
| US 7,320,970 | Low dose estrogen interrupted hormone replacement therapy Formerly held Lapsed on the fee record Ended Jan 22, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2020 | From the USPTO record |
| US 7,078,394 | Low dose estrogen interrupted hormone replacement therapy Formerly held Lapsed on the fee record Ended Jul 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2018 | From the USPTO record |
| US 6,326,390 | Use of adenosine A3 receptor antagonists to inhibit tumor growth Lapsed on the fee record Ended Dec 4, 2013 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2013 | From the USPTO record |
| US RE38,628 | Pharmaceutical compositions Term ended Term ended Dec 16, 2007 · From the USPTO record | Term ended | Term ended Dec 16, 2007 | From the USPTO record |
| US 4,474,787 | 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof Term ended Term ended no later than Oct 2, 2004 · Low confidence | Term ended | Term ended no later than Oct 2, 2004 | Low confidence |
| US 4,590,206 | Inhalation pharmaceuticals Term ended Term ended no later than May 20, 2006 · Low confidence | Term ended | Term ended no later than May 20, 2006 | Low confidence |
| US 4,760,072 | Solid nedocromil sodium, useful for the removal of obstructed air pathways Term ended Term ended no later than Jul 26, 2008 · Low confidence | Term ended | Term ended no later than Jul 26, 2008 | Low confidence |
| US 4,782,144 | 1-Carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof Formerly held Term ended Term ended no later than Nov 1, 2008 · Low confidence | Term ended | Term ended no later than Nov 1, 2008 | Low confidence |
| US 4,888,100 | Photochemical conversion of cephalosporins, 1-carba(1-dethia)cephalosporins and 1-oxa(1-dethia)cephalosporins Formerly held Term ended Term ended no later than Dec 19, 2009 · Low confidence | Term ended | Term ended no later than Dec 19, 2009 | Low confidence |